Use of pyrazolopyridines for the treatment of cognitive deficits
OwnerFabien Schweighoffer, Laurent Desire +2inventors
InventorsFabien Schweighoffer, Laurent Desire, Annelies Resink, Magali Rouquette
Life of this patent
Estimating the term…
Abstract
The invention relates to methods which are used to improve, increase or facilitate the cognition of individuals with neurodegenerative pathologies. More specifically, the invention relates to the use of compounds from the family of pyrazolopyridines in order to improve the cognitive faculties of individuals with neurodegenerative diseases. The invention can be used to improve the condition of individuals with different neurodegenerative diseases and, in particular, Alzheimer's disease and vascular dementia.
Claims9
1-6. (canceled)
A method of treating cognitive deficits in a patient having a neurodegenerative disease, the method comprising administering to the patient an effective amount of a compound of the pyrazolopyridine family.
A method of improving perceptive cognition in a patient having a neurodegenerative disease, the method comprising administering to the patient an effective amount of etazolate.
Dependencies are inferred from the claim text.